PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31286998-8	2019	FLT3ITD/NFATC1-AML is re-transplantable in secondary recipients and shows primary resistance to the FLT3ITD-kinase inhibitor quizartinib.	quizartinib	125-136	nuclear factor of activated T cells 1	Homo sapiens	8-14	
31286998-11	2019	CONCLUSIONS: NFATC1 expression causes FLT3ITD-induced transcriptome changes, which are associated with HSC transformation, quizartinib resistance, and a poor prognosis in AML.	quizartinib	123-134	nuclear factor of activated T cells 1	Homo sapiens	13-19